Search Results - "Varadhachary, Gauri Rajani"

Gender disparity in authorship of clinical trials leading to cancer drug approvals between 2008 and 2018: The glass ceiling of academic oncology by Chapman, Lynne O., Loree, Jonathan M., Anand, Seerat, Mendis, Shehara Ramyalini, McNeill, Lorna H, Raghav, Kanwal Pratap Singh, Varadhachary, Gauri Rajani

“…11048 Background: Authorship, expressly premier positions (first, corresponding, or senior author), in peer reviewed journals is widely acknowledged as…”
Get full text

Value appraisal of FDA approved cancer drugs over the past decade by Huey, Ryan, Anand, Seerat, Rogers, Jane Elizabeth, Dasari, Arvind, Varadhachary, Gauri Rajani, Gothwal, Anirudh, Loree, Jonathan M., Ellis, Lee M., Overman, Michael J., Raghav, Kanwal Pratap Singh

“…Abstract only 115 Background: Value based drug pricing is emerging as an imperative health care precept in recognition of the ever-increasing drug costs,…”
Get full text

Value appraisal of FDA approved cancer drugs over the past decade by Huey, Ryan, Anand, Seerat, Rogers, Jane, Dasari, Arvind, Varadhachary, Gauri Rajani, Gothwal, Anirudh, Loree, Jonathan M., Ellis, Lee M., Overman, Michael J., Raghav, Kanwal Pratap Singh

“…Abstract only e18385 Background: Value based drug pricing is emerging as an imperative health care precept in recognition of the ever-increasing drug costs,…”
Get full text

Adaptive Dose Escalation Trial of Stereotactic Body Radiation Therapy (SBRT) in combination with GC4419 in pancreatic cancer by Holmlund, Jon, Brookes, Melissa, Colbert, Lauren Elizabeth, Moningi, Shalini, Bhutani, Manoop S., Katz, Matthew H. G., Varadhachary, Gauri Rajani, Thall, Peter F., Herman, Joseph M., Taniguchi, Cullen M.

“…Abstract only TPS4164 Background: Local progression causes up to 30% of deaths from pancreatic cancer (PC) and is also a significant source of morbidity…”
Get full text

A retrospective analysis of antibiotics usage and effect on overall survival and progressive free survival in patients with metastatic pancreatic cancer by Mohindroo, Chirayu, Rogers, Jane E., Hasanov, Merve, Mizrahi, Jonathan, Overman, Michael J., Varadhachary, Gauri Rajani, Wolff, Robert A., Javle, Milind M., Fogelman, David R., Pant, Shubham, McAllister, Florencia

“…Abstract only e15781 Background: Recent studies have shown that the pancreatic ductal adenocarcinoma (PDAC)-associated gut microbiome can play a major in…”
Get full text

Female representation in clinical trials leading to FDA cancer drug approvals for gastrointestinal (GI) cancers between 2008 to 2018 by Mendis, Shehara Ramyalini, Anand, Seerat, Dasari, Arvind, Unger, Joseph M., Gothwal, Anirudh, Ellis, Lee M., Varadhachary, Gauri Rajani, Kopetz, Scott, Overman, Michael J., Raghav, Kanwal Pratap Singh, Loree, Jonathan M.

“…Abstract only 809 Background: Proportionate representation of women in health research is an area for improvement. This study aims to assess the representation…”
Get full text

Comprehensive genomic profiling of malignant peritoneal mesothelioma (MPeM) reveals key genomic alterations (GAs) distinct from malignant pleural mesothelioma (MPM) by Chapman, Lynne O., Overman, Michael J., Willett, Anneleis, Knafl, Mark, Fu, Szu-Chin, Malpica, Anais, Scally, Christopher, Mansfield, Paul F., Matamoros, Aurelio Aurelio, Morani, Ajaykumar, Woodman, Scott Eric, Sepesi, Boris, Mehran, Reza J., Haymaker, Cara L., Varadhachary, Gauri Rajani, Tsao, Anne S., Fournier, Keith, Raghav, Kanwal Pratap Singh

“…Abstract only 8557 Background: MPeM is a rare and aggressive cancer with very limited treatment options. Lack of dedicated research has impeded improvements in…”
Get full text

The effect of antibiotic use on survival of patients with resected pancreatic ductal adenocarcinoma by Hasanov, Merve, Mohindroo, Chirayu, Rogers, Jane, Prakash, Laura, Overman, Michael J., Varadhachary, Gauri Rajani, Wolff, Robert A., Javle, Milind M., Fogelman, David R., Pant, Shubham, Katz, Matthew H. G., Kim, Michael Paul, Tzeng, Ching-Wei David, McAllister, Florencia

“…Abstract only e15773 Background: Recent studies showed that gut microbial dysbiosis can affect carcinogenesis and tumor responses to therapies. Antibiotics,…”
Get full text

FOLFIRINOX in pancreatic cancer patients age 75 years or older by Mizrahi, Jonathan, Rogers, Jane, Hess, Kenneth R., Wolff, Robert A., Varadhachary, Gauri Rajani, Shroff, Rachna T., Ho, Linus, Fogelman, David R., Raghav, Kanwal Pratap Singh, Overman, Michael J., Pant, Shubham

“…Abstract only 362 Background: Although FOLFIRINOX (5-Fluorouracil + leucovorin + irinotecan + oxaliplatin) is now the standard of care for patients (pts) with…”
Get full text

A phase II trial of atezolizumab and bevacizumab in patients with relapsed/refractory and unresectable malignant peritoneal mesothelioma by Raghav, Kanwal Pratap Singh, Overman, Michael J., Liu, Suyu, Willett, Anneleis, Royal, Richard Eldon, Malpica, Anais, Scally, Christopher, Wistuba, Ignacio Ivan, Futreal, Andrew, Mahvash, Armeen, Yun, Cindy, Dervin, Shannon, Mckenna, Edward Francis, Schulze, Katja, Hwu, Patrick, Yao, James C., Kopetz, Scott, Varadhachary, Gauri Rajani, Halperin, Daniel M.

“…Abstract only 9013 Background: Malignant peritoneal mesothelioma (MPeM) is an orphan malignancy. No recommended/FDA approved therapies exist for salvage…”
Get full text

Prospective study for comprehensive genomic profiling (GP) in cancer of unknown primary (CUP): Feasibility, molecular landscape, and clinical utility in current era by Raghav, Kanwal Pratap Singh, Willett, Anneleis, Huey, Ryan, Dhillon, Nishat, Modha, Jignesh, Matamoros, Aurelio Aurelio, Estrella, Jeannelyn, Sanghavi, Kunal, Antov, Andrey, Choquette, Linda, Statz, Cara, Kelly, Kevin, Rowe, Shannon, Liu, Edison T., Rueter, Jens, Kopetz, Scott, Overman, Michael J., Varadhachary, Gauri Rajani

“…Abstract only 834 Background: CUP presents a unique niche and challenge for application of GP. Absence of a primary limits consensus regarding site-directed…”
Get full text

Adoptive transfer of tumor-infiltrating lymphocytes in patients with sarcomas, ovarian, and pancreatic cancers by Amaria, Rodabe Navroze, Bernatchez, Chantale, Forget, Marie-Andree, Haymaker, Cara L., Conley, Anthony Paul, Livingston, J. Andrew, Varadhachary, Gauri Rajani, Javle, Milind M., Maitra, Anirban, Tzeng, Ching-Wei David, Hinchcliff, Emily, Bayer, Virginia, Gasior, Yvonne, Hilton, Tyler, Celestino, Joseph, Rangel, Kelly M, Yuan, Ying, Lu, Karen H., Hwu, Patrick, Jazaeri, Amir A.

“…Abstract only TPS2650 Background: Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TIL) has a long history of efficacy in metastatic melanoma,…”
Get full text

Abstract CT220: A randomized multicenter phase Ib/II study to assess the safety and the immunological effect of chemoradiation therapy (CRT) in combination with Pembrolizumab (anti-PD1) to CRT alone in patients with resectable or borderline resectable pancreatic canc by Katz, Matthew H.G, Bauer, Todd W., Varadhachary, Gauri Rajani, Adams, Reid B., Lankford, Amy R., Petroni, Gina, Bullock, Timothy N., Slingluff, Craig L., Rahma, Osama E.

“…Abstract Background: Immunotherapy has recently emerged as a promising modality in cancer treatment, but little is known about the application of this modality…”
Get full text